"Urological Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION.
| Descriptor ID |
D064804
|
| MeSH Number(s) |
D27.505.954.944
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Urological Agents".
Below are MeSH descriptors whose meaning is more specific than "Urological Agents".
This graph shows the total number of publications written about "Urological Agents" by people in this website by year, and whether "Urological Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urological Agents" by people in Profiles.
-
Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries. Adv Ther. 2020 08; 37(8):3584-3605.
-
A Case Report of Fatal Desmethyl Carbodenafil Toxicity. J Anal Toxicol. 2017 Apr 01; 41(3):250-255.
-
Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial. Prostate. 2017 Jun; 77(8):908-919.
-
Review: Newer and older drugs do not differ for lower urinary tract symptoms due to benign prostatic hyperplasia. Ann Intern Med. 2016 10 18; 165(8):JC45.
-
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet. 2015 Jul 25; 386(9991):341-9.
-
Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease. Parkinsonism Relat Disord. 2015 May; 21(5):514-20.
-
It's not easy being blue-green. Ann Lab Med. 2013 Nov; 33(6):457-8.
-
Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score. Urology. 2013 Nov; 82(5):1076-81.
-
Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2213-20.
-
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013 Jul; 64(1):118-40.